The Technical Analyst
Select Language :
China Literature Limited [0772.HK]

Exchange: HKSE Industry: Internet Content & Information

China Literature Limited Price, Forecast, Insider, Ratings, Fundamentals & Signals

China Literature Limited is listed at the  Exchange

0.50% HKD30.05

America/New_York / 3 mai 2024 @ 04:08


China Literature Limited: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 30 753 mill
EPS: 0.850
P/E: 35.35
Earnings Date: Mar 18, 2024
SharesOutstanding: 1 023.39 mill
Avg Daily Volume: 4.61 mill
RATING 2024-05-03
B+
Neutral
RATINGS
Rating CashFlow: Neutral
Return On Equity: Neutral
Return On Asset: Buy
DE: Sell
P/E: Buy
Price To Book: Neutral
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenuen/an/an/a
Gr.Profitn/an/an/a
Ebitn/an/an/a
Asset n/an/an/a
Debt
PE RATIO: COMPANY / SECTOR
2.13x
Company: PE 35.35 | sector: PE 16.62
PE RATIO: COMPANY / INDUSTRY
1.86x
Company: PE 35.35 | industry: PE 19.05
DISCOUNTED CASH FLOW VALUE
HKD12.25
(-59.23%) HKD-17.80
Date: 2024-05-03
Expected Trading Range (DAY)

HKD 28.55 - 31.55

( +/- 4.98%)
ATR Model: 14 days

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - HKD30.00
Forecast 2: 16:00 - HKD30.00
Forecast 3: 16:00 - HKD30.00
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price HKD30.05 (0.50% )
Volume 3.46 mill
Avg. Vol. 4.61 mill
% of Avg. Vol 75.04 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for China Literature Limited

Last 12 Months

Last 12 months chart data with high, low, open and close for China Literature Limited

RSI

Intraday RSI14 chart for China Literature Limited

Last 10 Buy & Sell Signals For 0772.HK

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            China Literature Limited

0772.HK

China Literature Limited, an investment holding company, operates an online literature platform in the People's Republic of China. The company promotes intellectual properties primarily through its online literature platforms, such as QQ Reading and Qidian; and New Classics Media, a film and TV drama series production house. It is also involved in the self-operated channels business on partner distribution platforms. In addition, the company licenses the content to third-party partners for distribution, as well as offers online paid reading and content adaptations into various entertainment formats. Further, it provides reading, copyright commercialization, and writer cultivation and brokerage services; and operates text work reading and related open platform through technology methods and digital media, including personal computers, Internet, and mobile network. Additionally, the company engages in the production and distribution of television series, web series, and films; licensing and distribution of film and television properties; licensing copyrights; sale of physical books; and operation of in-house online games, etc. The company was founded in 2002 and is headquartered in Shanghai, the People's Republic of China. China Literature Limited is a subsidiary of Tencent Holdings Limited.

Last 10 Buy Signals

Date Signal @
YAR.OLMay 3 - 08:29NOK314.80
HEX.OLMay 3 - 08:28NOK18.04
ELK.OLMay 3 - 08:25NOK19.28
CRAYN.OLMay 3 - 08:24NOK82.75
SATS.OLMay 3 - 08:21NOK17.32
MEDI.OLMay 3 - 08:21NOK178.00
XCADUSDMay 3 - 08:330.746
NEL.OLMay 3 - 08:18NOK5.18
YFIIUSDMay 3 - 08:31$473.50
ABL.OLMay 3 - 08:1711.65

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.